ANALYST VIEW - Drug of Hungary's Richter could be facing new rival

Jefferies publishes opinion

ANALYST VIEW - Jefferies ups target price for Hungary's Richter

Share price close to all-time high

ANALYST VIEW - Jefferies reviews Richter 'wonder' drug

Vraylar sequential growth to continue after lockdown

ANALYST VIEW - Jefferies publishes research on Hungary's Richter

Target price, rating remain unchanged

ANALYST VIEW - Jefferies expects market to 'like' Richter deal

Endorses spending of Vraylar cash

Richter is a top pick, share price may take off

Management considered overly conservative

ANALYST VIEW - Jefferies sharply raises target price for Hungary's Richter

Rating upgraded to 'Buy' from 'Underperform'

ANALYST VIEW - Jefferies ups targert price for Hungary's Richter

Recommendation remains 'Hold', though.

ANALYST VIEW - Jefferies lowers target price for Hungary's Richter

To HUF 5,470 from HUF 5,695.

ANALYST VIEW - Hungary's Richter gets 'Hold' rating from Jefferies

After release of Q1 earnings report.

ANALYST VIEW - Jefferies downgrades Hungary's Richter over Esmya woes

Slashes target price, removes Esmya from model.

Last week's bad news to weigh on Hungary's Richter for months - analysts

Jefferies comment EMA probe, Q4 results.

INSTANT VIEW - EMA recommends temporary measures for Richter’s Esmya

Sentiment to be impacted by cautionary measures.

ANALYST VIEW - Jefferies raises target price for Hungary's Richter

After robust Q3 figures.

ANALYST VIEW - Jefferies trims target price for Hungary's Richter

'Buy' rating remains.

ANALYST VIEW - Jefferies sharply raises target price for Hungary's Richter

The rating is 'Buy'.

ANALYST VIEW - Jefferies raises target price for Hungary's Richter

ANALYST VIEW - Goldman Sachs also lowers target price for Hungary's Richter

ANALYST VIEW - Jefferies downgrades Hungary's Richter

ANALYST VIEW - Jefferies raises target price sharply for Hungary's Richter